Extensive molecular and clinical heterogeneity in patients with histologically diagnosed cns-pnet treated as a single entity: a report from the children’s oncology group randomized ACNS0332 trial
Children with histologically diagnosed high-risk medulloblastoma, supratentorial primitive neuroectodermal tumor of the CNS (CNS-PNET), and pineoblastoma (PBL) have had poor survival despite intensive treatment. We included these patients in this Children’s Oncology Group trial. Molecular profiling...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 1, 2018
|
| In: |
Journal of clinical oncology
Year: 2018, Jahrgang: 36, Heft: 34, Pages: 3388-3395 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2017.76.4720 |
| Online-Zugang: | Resolving-System, Volltext: http://dx.doi.org/10.1200/JCO.2017.76.4720 Verlag, Volltext: http://ascopubs.org/doi/10.1200/JCO.2017.76.4720 
|
| Verfasserangaben: | Eugene I. Hwang, Marcel Kool, Peter C. Burger, David Capper, Lukas Chavez, Sebastian Brabetz, Chris Williams-Hughes, Catherine Billups, Linda Heier, Alok Jaju, Jeff Michalski, Yimei Li, Sarah Leary, Tianni Zhou, Andreas von Deimling, David T.W. Jones, Maryam Fouladi, Ian F. Pollack, Amar Gajjar, Roger J. Packer, Stefan M. Pfister, and James M. Olson |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1584499524 | ||
| 003 | DE-627 | ||
| 005 | 20220815065436.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181127s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2017.76.4720 |2 doi | |
| 035 | |a (DE-627)1584499524 | ||
| 035 | |a (DE-576)514499524 | ||
| 035 | |a (DE-599)BSZ514499524 | ||
| 035 | |a (OCoLC)1341024350 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hwang, Eugene |e VerfasserIn |0 (DE-588)1172312079 |0 (DE-627)1041114036 |0 (DE-576)514504110 |4 aut | |
| 245 | 1 | 0 | |a Extensive molecular and clinical heterogeneity in patients with histologically diagnosed cns-pnet treated as a single entity |b a report from the children’s oncology group randomized ACNS0332 trial |c Eugene I. Hwang, Marcel Kool, Peter C. Burger, David Capper, Lukas Chavez, Sebastian Brabetz, Chris Williams-Hughes, Catherine Billups, Linda Heier, Alok Jaju, Jeff Michalski, Yimei Li, Sarah Leary, Tianni Zhou, Andreas von Deimling, David T.W. Jones, Maryam Fouladi, Ian F. Pollack, Amar Gajjar, Roger J. Packer, Stefan M. Pfister, and James M. Olson |
| 264 | 1 | |c December 1, 2018 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.11.2018 | ||
| 520 | |a Children with histologically diagnosed high-risk medulloblastoma, supratentorial primitive neuroectodermal tumor of the CNS (CNS-PNET), and pineoblastoma (PBL) have had poor survival despite intensive treatment. We included these patients in this Children’s Oncology Group trial. Molecular profiling later revealed tumor heterogeneity that was not detectable at protocol inception. Enrollment of patients with CNS-PNET/PBL was subsequently discontinued, and outcomes for this part of the study are reported here. | ||
| 700 | 1 | |a Kool, Marcel |e VerfasserIn |0 (DE-588)1058669753 |0 (DE-627)797393560 |0 (DE-576)414823842 |4 aut | |
| 700 | 1 | |a Capper, David |d 1979- |e VerfasserIn |0 (DE-588)133950751 |0 (DE-627)558829902 |0 (DE-576)300212402 |4 aut | |
| 700 | 1 | |a Chavez, Lukas |e VerfasserIn |0 (DE-588)1172311382 |0 (DE-627)1041112599 |0 (DE-576)514503246 |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Jones, David T. W. |e VerfasserIn |0 (DE-588)1058669672 |0 (DE-627)79739334X |0 (DE-576)414823583 |4 aut | |
| 700 | 1 | |a Pfister, Stefan |d 1974- |e VerfasserIn |0 (DE-588)123850215 |0 (DE-627)706450930 |0 (DE-576)293908400 |4 aut | |
| 700 | 1 | |a Brabetz, Sebastian |e VerfasserIn |0 (DE-588)1154706559 |0 (DE-627)1018125434 |0 (DE-576)501181172 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 36(2018), 34, Seite 3388-3395 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Extensive molecular and clinical heterogeneity in patients with histologically diagnosed cns-pnet treated as a single entity a report from the children’s oncology group randomized ACNS0332 trial |
| 773 | 1 | 8 | |g volume:36 |g year:2018 |g number:34 |g pages:3388-3395 |g extent:8 |a Extensive molecular and clinical heterogeneity in patients with histologically diagnosed cns-pnet treated as a single entity a report from the children’s oncology group randomized ACNS0332 trial |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2017.76.4720 |x Resolving-System |x Verlag |3 Volltext |
| 856 | 4 | 0 | |u http://ascopubs.org/doi/10.1200/JCO.2017.76.4720 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181127 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1154706559 |a Brabetz, Sebastian |m 1154706559:Brabetz, Sebastian |d 910000 |d 910500 |e 910000PB1154706559 |e 910500PB1154706559 |k 0/910000/ |k 1/910000/910500/ |p 6 | ||
| 998 | |g 123850215 |a Pfister, Stefan |m 123850215:Pfister, Stefan |d 910000 |d 910500 |e 910000PP123850215 |e 910500PP123850215 |k 0/910000/ |k 1/910000/910500/ |p 21 | ||
| 998 | |g 1058669672 |a Jones, David T. W. |m 1058669672:Jones, David T. W. |d 50000 |e 50000PJ1058669672 |k 0/50000/ |p 16 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 15 | ||
| 998 | |g 1172311382 |a Chavez, Lukas |m 1172311382:Chavez, Lukas |d 50000 |e 50000PC1172311382 |k 0/50000/ |p 5 | ||
| 998 | |g 133950751 |a Capper, David |m 133950751:Capper, David |p 4 | ||
| 998 | |g 1058669753 |a Kool, Marcel |m 1058669753:Kool, Marcel |d 50000 |e 50000PK1058669753 |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1584499524 |e 3034164785 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 27.11.2018"],"language":["eng"],"person":[{"family":"Hwang","role":"aut","display":"Hwang, Eugene","given":"Eugene"},{"given":"Marcel","family":"Kool","role":"aut","display":"Kool, Marcel"},{"family":"Capper","role":"aut","display":"Capper, David","given":"David"},{"given":"Lukas","display":"Chavez, Lukas","family":"Chavez","role":"aut"},{"given":"Andreas von","display":"Deimling, Andreas von","role":"aut","family":"Deimling"},{"given":"David T. W.","display":"Jones, David T. W.","family":"Jones","role":"aut"},{"role":"aut","family":"Pfister","display":"Pfister, Stefan","given":"Stefan"},{"family":"Brabetz","role":"aut","display":"Brabetz, Sebastian","given":"Sebastian"}],"recId":"1584499524","id":{"doi":["10.1200/JCO.2017.76.4720"],"eki":["1584499524"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Eugene I. Hwang, Marcel Kool, Peter C. Burger, David Capper, Lukas Chavez, Sebastian Brabetz, Chris Williams-Hughes, Catherine Billups, Linda Heier, Alok Jaju, Jeff Michalski, Yimei Li, Sarah Leary, Tianni Zhou, Andreas von Deimling, David T.W. Jones, Maryam Fouladi, Ian F. Pollack, Amar Gajjar, Roger J. Packer, Stefan M. Pfister, and James M. Olson"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"December 1, 2018"}],"relHost":[{"language":["eng"],"recId":"313116962","type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"36","text":"36(2018), 34, Seite 3388-3395","extent":"8","issue":"34","year":"2018","pages":"3388-3395"},"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"pubHistory":["1.1983 -"],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"disp":"Extensive molecular and clinical heterogeneity in patients with histologically diagnosed cns-pnet treated as a single entity a report from the children’s oncology group randomized ACNS0332 trialJournal of clinical oncology","corporate":[{"role":"isb","display":"American Society of Clinical Oncology"}],"origin":[{"publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","dateIssuedKey":"1983"}],"id":{"issn":["1527-7755"],"eki":["313116962"],"zdb":["2005181-5"]},"title":[{"subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology","title":"Journal of clinical oncology"}]}],"physDesc":[{"extent":"8 S."}],"title":[{"title_sort":"Extensive molecular and clinical heterogeneity in patients with histologically diagnosed cns-pnet treated as a single entity","subtitle":"a report from the children’s oncology group randomized ACNS0332 trial","title":"Extensive molecular and clinical heterogeneity in patients with histologically diagnosed cns-pnet treated as a single entity"}]} | ||
| SRT | |a HWANGEUGENEXTENSIVEM1201 | ||